No discussion of the HCV arena would be complete without Bavituximab, so here is PPHM’s latest PR: finance.yahoo.com/news/Peregrine-Presents-Phase-Ib-iw-304801467.html?x=0&.v=1 (The above is facetious, of course.)LOL I assume you meant to refer to both the HCV and HIV arenas. ; )